Avandia® (rosiglitazone maleate)

Food & Drug Administration

Center for Drug Evaluation and Research

Endocrinologic and Metabolic Drugs Advisory Committee

April 22, 1999

SmithKline Beecham Pharmaceuticals

Next slide

Back to first slide

View graphic version